Correlation Between Medicofarma Biotech and PCF Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and PCF Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and PCF Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and PCF Group SA, you can compare the effects of market volatilities on Medicofarma Biotech and PCF Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of PCF Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and PCF Group.

Diversification Opportunities for Medicofarma Biotech and PCF Group

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Medicofarma and PCF is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and PCF Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCF Group SA and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with PCF Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCF Group SA has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and PCF Group go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and PCF Group

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to generate 1.92 times more return on investment than PCF Group. However, Medicofarma Biotech is 1.92 times more volatile than PCF Group SA. It trades about -0.08 of its potential returns per unit of risk. PCF Group SA is currently generating about -0.21 per unit of risk. If you would invest  81.00  in Medicofarma Biotech SA on September 2, 2024 and sell it today you would lose (43.00) from holding Medicofarma Biotech SA or give up 53.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

Medicofarma Biotech SA  vs.  PCF Group SA

 Performance 
       Timeline  
Medicofarma Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
PCF Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PCF Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Medicofarma Biotech and PCF Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicofarma Biotech and PCF Group

The main advantage of trading using opposite Medicofarma Biotech and PCF Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, PCF Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCF Group will offset losses from the drop in PCF Group's long position.
The idea behind Medicofarma Biotech SA and PCF Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets